Award Winners

The ISPOR Research Presentation Podium and Poster Awards were established in 1998 to recognize the scientific merit of podium and poster presentations of the ISPOR Annual International Meetings, Annual European Congresses, Asia-Pacific and Latin America Conferences.

This year, the ISPOR judges evaluated podium presentations and nominated poster presentations. All podium presentations are considered for an award. Poster presentations in the top 5%, based on abstract review score, are considered and eligible for a poster presentation award. 

Evaluations of scientific merit were based upon the following criteria:

QUALITY OF RESEARCH STUDY
• Research design is appropriate and transparent
• Data sources are appropriate and transparent
• Data analyses are appropriate and transparent
• Results are included and are transparent and comprehensible
• Uncertainty of results is addressed appropriately
• Conclusions are consistent with the results

QUALITY OF PRESENTATION
• Objectives/research questions are clearly stated, and objectives are addressed
• Factual information is kept separate from interpretations or implications / unbiased presentations
• Implications, as presented, are easy to understand
• Clarity of presentation

Click through for more information on the criteria used for judging podiums and posters. 

THE RECIPIENTS ARE…

Best General Poster Research Presentations

PMU53: Use of Guyot Algorithm to Estimate Hazard Ratios from Kaplan-Meier Curves
Presenting Author: Shih Hao Lee, Intuitive Surgical, USA

PBI19: Replicating Clinical Trial Exclusion Criteria in a Claims-Based Cohort of Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Initiating Intravenous Immunoglobulin (IVIG) Treatment
Presenting Author: Colin Anderson-Smits, Shire US Inc., a Takeda company, USA

PNS82: The Methods for Incorporating Carer HRQoL Should be More Clearly Defined By NICE    
Presenting Author: Lucy Richardson, Pfizer Ltd, United Kingdom

Best Student Poster Research Presentations             

PNS15: Cost-Effectiveness Analysis of Pharmacogenetic Testing in Opioid Analgesia in Pediatric Population Undergoing Surgery
Presenting Author: Arun Kumar, University of Minnesota, College of Pharmacy, USA

PCV10: Cost-Effectiveness of Intensive VS. Moderate Hypertension Treatment in US Adults Age 65 and Older at High Risk of Atherosclerotic Cardiovascular Disease
Presenting Author: Shu Huang, University of Florida College of Pharmacy, USA

PBI5: Comparative Effectiveness and Treatment Persistence of TNFi vs. non-TNFi in Juvenile Idiopathic Arthritis
Presenting Author: Emma Xiaomeng Yue, University of Cincinnati, USA

PBI2: Real-World Evaluation of Biosimilar Bevacizumab-awwb versus Reference Bevacizumab in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer in a U.S. Integrated Healthcare Delivery System: 6-Month Interim Analysis 
Presenting Author: Catherine Pham, Kaiser Permanente/Chapman University School of Pharmacy, USA

PCN128: Incidence and Associated Risks of New Persistent and Continued Opioid Use in Patients with Cancer Receiving Radiotherapy 
Presenting Author: Elena Fernandez, Monument Analytics, USA

PCN18: Cetuximab Versus Bevacizumab in Metastatic Colorectal Cancer: A Comparative Effectiveness and Patient-Reported Outcomes Multicohort Study
Presenting Author: Rui Pedro Marques, Centro Hospitalar Universitario de Lisboa Norte, Portugal

CO4: Predictors of Inpatient Relapse in Multiple Sclerosis Patients Using First-Line Disease Modifying Therapies: A Machine Learning Study of Real-World Data
Presenting Author: Zeynep Icten, Panalgo, USA

EC4: Real-World Healthcare Costs in Patients with Classical Hodgkin Lymphoma Treated with Pembrolizumab and Nivolumab in the United States    
Presenting Author: Monika Raut, Merck & Co., Inc., USA

CO3: Comparison of Goal Attainment and Measures of Function in Two Dementia Clinical Trials.    
Presenting Author: Justin Stanley, Ardea Outcomes, Canada

EC2: Modeling Approaches to Estimate Realized Real Option Value of Ipilimumab in Metastatic Melanoma    
Presenting Author: Woojung Lee, University of Washington, USA

PB1: Differences in Adherence and Healthcare Utilization between Users of Analog Vial, Analog Pen, and Human Insulin    
Presenting Author: Sohul Shuvo, University of Tennessee Health Science Center, USA

AI2: The Impact of Including Race and Ethnicity in Risk Prediction Models on Racial Bias
Presenting Author: Sara Khor, University of Washington, USA

CN1: Patterns of Utilization and Implementation Experiences of Oncology Monoclonal Antibodies (MABS) Biosimilars in the U.S.: From BOTH Payers and Healthcare Professionals (HCPS) Perspectives    
Presenting Author: Jingyan Yang, Pfizer Inc, USA

CE1: A Modeled Health Outcomes Evaluation of Darolutamide Plus Androgen Deprivation Therapy for High-Risk NON-Metastatic Castration-Resistant Prostate Cancer in China    
Presenting Author: Shanlian Hu, School of Public Health, Fudan University, China

SC2: Trends in Diagnostic Prevalence, Treatment Patterns, and Healthcare Resource Utilization of Pediatric Food Allergy Patients in the United States, 2008-2018    
Presenting Author: Kayla Mills, Eli Lilly and Company, USA